Author

Joshua D. Kidd

ALS Therapy Development Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Alan GilliD· 1 shared Andrew Moreno· 1 shared Fernando G. VieiraiD· 1 shared Kenneth Thompson· 1 shared Steven PerriniD· 1 shared Theo HatzipetrosiD· 1 shared Valerie R. Tassinari· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Alan GillORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PERK modulation, with GSK2606414, Sephin1 or salubrinal, failed to produce therapeutic benefits in the SOD1G93A mouse model of ALS

Fernando G. Vieira, Valerie R. Tassinari, Joshua D. Kidd, Andrew Moreno, Kenneth Thompson, Steven Perrin, Alan Gill, Theo Hatzipetros

This study evaluates three PERK modulators in an ALS mouse model and finds they do not provide therapeutic benefits, with some effects possibly mediated through PERK-independent mechanisms.

PLoS ONE · Feb 15, 2024Peer-reviewedNeuroscience